Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology ( PETACH TIKVA Israel--(BUSINESS WIRE)--...)

HOME >> MEDICINE >> TECHNOLOGY

Can-Fite Proceeds with Development of Third Drug; Progress in,Development of CF502 Will Be Presented at the Annual European,Congress of Rheumatology

PETACH TIKVA, Israel--(BUSINESS WIRE)--Jun 14, 2007 - Can-Fite BioPharma (TASE:CFBI), a biotechnology company traded on the Tel Aviv Stock Exchange Exchange, proceeds with the development of its third drug CF502; this is in addition to CF101, which is currently in clinical trials and CF102, which is in preclinical phases. This weekend Can-Fite will present at the EUALR annual congress of rheumatology in-vitro and in vivo study results showing effective anti-inflammatory activity for CF502. The EUALR congress is highly regarded and attracts global leaders in the Rheumatology arena.

The chemical structure of CF502 differs from that of the Company's first two drugs CF101 and CF102, and is characterized by higher affinity and selectivity to the A3 adenosine receptor, which is targeted by the Can-Fite's drugs. The drug attacks inflammatory cells and leads to programmed cell death (apoptosis) and suppression of the inflammatory process. Can-Fite is using human cells to investigate the effects and mechanism of action of CF502. The Company is currently finalizing the development of CF502 synthesis process, before entering preclinical and clinical development phases.

Can-Fite will present at the rheumatology congress in-vitro data showing that CF502 specifically targets inflammatory cells and does not affect healthy cells, and will also present the drug's molecular mechanism of action. In addition in vivo data showing marked anti-inflammatory effects of CF502 will be reported. The Company will also present new data on the expression of A3 adenosine receptor in various autoimmune diseases. High expression of this receptor is directly correlated with response of inflammatory cells to this drug.

Prof. Pnina Fishman, CEO of Can-Fite: "I am pleased with the rapid progress in the CF502 development program and with the in-vitro and in vivo trial results showing impressive anti-inflammatory activity for this drug.
'"/>

Page: 1 2
Related medicine technology :

1. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
2. Pieris Progresses Development of its Proprietary Biotherapeutics Platform: Successful Demonstration of Dual Targeting With Duocalin(R) Technology
3. Anadys Pharmaceuticals Nominates ANA598, a Small-Molecule, Non-Nucleoside Inhibitor of The NS5b Polymerase, as a Candidate for Clinical Development in Chronic Hepatitis C Virus Infection
4. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
5. CuraGen Presents Update on Clinical Development Program for Belinostat
6. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
7. DURECT Provides an Update to the Memryte Program Under Development by Voyager Pharmaceutical Corp
8. ImClone Systems Showcases Extensive Research and Development Program at the AACR Annual Meeting
9. Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
10. Biomira Selects PX-866 as Clinical Development Candidate and Presents Promising Preclinical Data at AACR
11. Newly Released Canadian Data Links Vaccines with Pervasive Developmental Disorder

Post Your Comments:

(Date:5/16/2013)... Amgen (NASDAQ: AMGN ) will participate in ... 2013, at the Sheraton New York Times Square in ... Eastern Daylight Time. Joseph P. Miletich , ... Amgen, will present at the conference. Live audio of the ... website, www.amgen.com , under Investors. A replay of the ...

(Date:5/16/2013)... , May 16, 2013 ... in the U.S. to access the widely-used OrthoView digital ... PC and Internet connection to get started. ... software for over 10 years, is dedicated to enabling ... with digital x-ray images, when printed film is unavailable. ...

(Date:5/16/2013)... YORK , May 16, 2013 Developers of ... sends patient reminders have emerged as grand prize winners in ... innovation challenge funded by Boehringer Ingelheim and organized by ... Stein , John Langhauser and ... from the United States will ...

Breaking Medicine Technology:OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2 Wireless Pill Bottle Wins Healthcare Innovation World Cup 2 Wireless Pill Bottle Wins Healthcare Innovation World Cup 3 Wireless Pill Bottle Wins Healthcare Innovation World Cup 4 Wireless Pill Bottle Wins Healthcare Innovation World Cup 5

[0] Amgen To Present At The UBS Global Life Sciences Conference [0] OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons [0] Wireless Pill Bottle Wins Healthcare Innovation World Cup

... Reportlinker.com announces that a new market research ... Immuno Chemistry Reagents, Analyzers and ... Landscape and Market Forecasts to 2017 ... Immuno Chemistry Reagents, Analyzers and Test Kits ...

... April 12, 2011 Reportlinker.com announces that a ... catalogue: Asia-Pacific Nephrology and ... http://www.reportlinker.com/p0334119/Asia-Pacific-Nephrology-and-Urology-Devices-Market-Outlook-to-2017.html Asia-Pacific ... Summary GlobalData,s ...

Reportlinker Adds Immuno Chemistry Reagents, Analyzers and Test Kits - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 Reportlinker Adds Asia-Pacific Nephrology and Urology Devices Market Outlook to 2017

(Date:5/19/2013)... Gourmands and foodies everywhere have long recognized ginger as ... to both sweet and savory dishes; now, a study ... the spicy root also may have properties that help ... the study will be presented at the ATS 2013 ... tightening of the bronchial tubes that carry air into ...

(Date:5/19/2013)... Coral Springs, FL (PRWEB) May 19, 2013 ... education. It is also a city with one of the ... by ranking it eleventh in their Best Places for Business ... Places for Relocation lists. Omaha is centrally located in ... the stalwarts of industry located there. The producers of ...

(Date:5/19/2013)... New York, New York (PRWEB) May 19, 2013 ... move forward in a federal litigation now underway in ... to a Case Management Order dated May 3rd, the ... the Bellwether Nominee Pool to eight cases rather than ... litigation is scheduled for Thursday, May 23rd. (In re: ...

(Date:5/19/2013)... 19, 2013 Grinding your teeth at ... sleep, or annoying your spouse. At the same time, ... Central (“Snoring and Teeth Grinding Could Be a Sign ... grinding can be hard to prevent. Apparently, Obstructive Sleep ... one of its symptoms is a habit of teeth ...

(Date:5/19/2013)... These molecular diagnostics market reports provide ... Italy, Germany and France:, Major ... as well as key economic, regulatory, demographic, social ... the next five years. , An extensive ... formats, detection methodologies, trends in testing automation and ...

Breaking Medicine News(10 mins):Health News:Ginger compounds may be effective in treating asthma symptoms 2 Health News:Editions TV Announces May Air Dates for Omaha, Nebraska 2 Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2 Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3 Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2 Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3 Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4

[0] Ginger compounds may be effective in treating asthma symptoms [0] Editions TV Announces May Air Dates for Omaha, Nebraska [0] Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation [0] Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder [0] Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com

... Corporation (NYSE: THC ) announces that ... the company,s 2009 Circle of Excellence. ... honors Tenet hospitals that have achieved the highest ... Key metrics used to evaluate the hospitals were ...

... Lunch April 29 PITTSBURGH, April 27 Walking one mile ... calories in an average candy bar, a person would need ... Experts agree on the many health benefits of moderate-level physical ... and most inexpensive ways to exercise. Highmark employees will be ...

... officials checking persons entering U.S. for signs of sickness , , ... cases of swine flu in the United States has doubled ... New York City high school that had previously reported eight ... , The officials also said they were tightening their travel ...

... 27 American Med Tech, Inc. (Pink Sheets: ... kit for swine flu based on the germ ... http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO ) "We spent ... existing inventory already boxed in pre-paid overnight FED-EX ...

... to a worrisome rise in childhood obesity, Florida school ... year, but there is little research available to determine ... with a $2.2 million grant from the National Institutes ... Schools, a Florida State University College of Medicine researcher ...

... 27 Lung Cancer Alliance announced that a ... cancer,s high mortality rate was introduced with bipartisan ... today.(Logo: http://www.newscom.com/cgi-bin/prnh/20081016/LCALOGO )"We ... multi-agency approach to lung cancer in both Houses ...

Cached Medicine News:Health News:Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award 2 Health News:Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award 3 Health News:Highmark Puts Employee Health First on National Walk@Lunch Day 2 Health News:Highmark Puts Employee Health First on National Walk@Lunch Day 3 Health News:40 Swine Flu Cases Now Reported in U.S. 2 Health News:40 Swine Flu Cases Now Reported in U.S. 3 Health News:40 Swine Flu Cases Now Reported in U.S. 4 Health News:40 Swine Flu Cases Now Reported in U.S. 5 Health News:'Nano-Silver Swine Flu Protection' 2 Health News:'Nano-Silver Swine Flu Protection' 3 Health News:FSU researcher wins $2.2 million grant to study childhood obesity 2 Health News:FSU researcher wins $2.2 million grant to study childhood obesity 3 Health News:Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill 2 Health News:Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill 3

Houston Northwest Medical Center Receives Prestigious Tenet Circle of Excellence Award Highmark Puts Employee Health First on National Walk@Lunch Day 40 Swine Flu Cases Now Reported in U.S.'Nano-Silver Swine Flu Protection'FSU researcher wins $2.2 million grant to study childhood obesity Lung Cancer Research Bill Introduced in the U.S. House of Representatives: Companion to Senate Mortality Reduction Bill

... the most advanced visual electrodiagnostic system ... of retinal and optic nerve function. ... drives this powerful computer-controlled instrument. With ... pattern stimulation, rapid Ganzfeld flash rate ...

... The Universal Biomedical Amplifier (UBA-4204) ... true DC signal amplification and ... commonly seen amplifier problems of ... saturation. These features make the ...

The STALIF stand-alone anterior lumbar fusion cage is the latest product development from Surgicraft. STALIF is the natural evolution of the Hartshill Horseshoe, which has over 10 years clinical suc...

... PACHETTE 3 will enable eye care professionals ... utilizing improved ultrasound technology. The PACHETT 3 ... algorithm used in all the DGH pachymeters ... DGH Model 555 PACHETTE 3 is capable ...

Medicine Products:

UTAS-E 3000mf Universal Biomedical Amplifier (UBA-4204)STALIF™DGH Pachette 3